Literature DB >> 17350667

Pulmonary thromboendarterectomy: a clinicopathologic study of 200 consecutive pulmonary thromboendarterectomy cases in one institution.

Joan Bernard1, Eunhee S Yi.   

Abstract

Approximately 2000 patients underwent pulmonary thromboendarterectomy (PTE) to date at University of California, San Diego. We retrospectively reviewed the clinicopathologic manifestations of 200 consecutive PTE cases from June 2004 to February 2006 with an emphasis on the histopathologic spectrum of chronic thromboembolic disease. Pathology reports and all histologic sections of study cases were examined. Pertinent clinical data were obtained from operative reports and medical records. In the study group, there were 2 cases (1 man, 1 woman) of pulmonary artery sarcomas and 1 case of metastatic tumor emboli from a testicular germ cell tumor. Two patients (both women) showed histologic evidence of arteritis without clinically apparent systemic vasculitis. The remaining 195 PTE patients with chronic thromboembolic disease consisted of 97 women and 98 men with a mean age of 52 (range, 17-83) and 51 (range, 16-82), respectively. Bilateral PTE was performed in 191, and unilateral PTE was performed in 4 (right and left, 2 each) patients. History of deep vein thrombosis was noted in 38.5%, and coagulation abnormalities were documented in 16.4% of these 195 cases. Grossly, the volumes of PTE specimens were greater in men than in women and on the right side than on the left in both men and women. Microscopically, the thrombi were recent fibrinous clot in 0.8%, mixed fibrinous and organizing in 45%, and old organized in 54.2% of specimens. Inflammation within the thrombi was usually mild but moderate and severe inflammation was found in 13.4% and 1.3% of specimens, respectively. Exuberant epithelioid granulomas were seen within the thrombi in one patient who had a history of sarcoidosis. Collections of foamy histiocytes and/or cholesterol clefts were found in 45%, and calcification was present in 11.5% of specimens. One case revealed diffuse myofibroblastic proliferation in a highly inflammatory background containing numerous plasma cells, reminiscent of inflammatory myofibroblastic tumor. In summary, pathology of PTE specimens in our study group encompassed remodeling of thrombi at various stages with variable degrees of inflammation and cellularity, granulomas associated with sarcoidosis, a rare case showing features of inflammatory myofibroblastic tumor, primary or metastatic malignancy, and isolated pulmonary arteritis.

Entities:  

Mesh:

Year:  2007        PMID: 17350667     DOI: 10.1016/j.humpath.2006.11.017

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Neovascular capacity of endothelial progenitor cells in the adult pulmonary circulation.

Authors:  Susan Majka; Diego F Alvarez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-04-03       Impact factor: 5.464

3.  A more aggressive approach to emergency embolectomy for acute pulmonary embolism.

Authors:  Basar Sareyyupoglu; Kevin L Greason; Rakesh M Suri; Mark T Keegan; Joseph A Dearani; Thoralf M Sundt
Journal:  Mayo Clin Proc       Date:  2010-09       Impact factor: 7.616

Review 4.  Chronic Thromboembolic Pulmonary Hypertension: the Bench.

Authors:  George A Alba; Deepak Atri; Sriranjani Darbha; Inderjit Singh; Victor F Tapson; Michael I Lewis; Hyung J Chun; Yen-Rei Yu; Bradley A Maron; Sudarshan Rajagopal
Journal:  Curr Cardiol Rep       Date:  2021-08-19       Impact factor: 2.931

Review 5.  Chronic thromboembolic pulmonary hypertension: detection, medical and surgical treatment approach, and current outcomes.

Authors:  David S Poch; William R Auger
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

6.  High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Authors:  Timothy A Morris; James J Marsh; Peter G Chiles; Marisa M Magaña; Ni-Cheng Liang; Xavier Soler; Daniel J Desantis; Debby Ngo; Virgil L Woods
Journal:  Blood       Date:  2009-05-06       Impact factor: 22.113

Review 7.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

8.  Densitometric CT evaluation of acute and chronic thromboembolic filling defects of the pulmonary arteries before and after contrast injection.

Authors:  F De Luca; C Modolon; F Buia; D Attinà; P Fughelli; M L Bacchi Reggiani; N Galiè; M Zompatori
Journal:  Radiol Med       Date:  2012-05-14       Impact factor: 3.469

9.  Characterization of proximal pulmonary arterial cells from chronic thromboembolic pulmonary hypertension patients.

Authors:  Rozenn Quarck; Marijke Wynants; Alicja Ronisz; Maria Rosario Sepulveda; Frank Wuytack; Dirk Van Raemdonck; Bart Meyns; Marion Delcroix
Journal:  Respir Res       Date:  2012-03-27

10.  A 51-year-old man with chronic cough and left hilar prominence.

Authors:  Ismini Kourouni; Scott W Aesif; Stephen W Tamarkin; Michael Bolen; Edward Sivak; Ziad Shaman; Ila Tamaskar; Vaia Florou
Journal:  Breathe (Sheff)       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.